Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8586023 Cell capable of expressing exogenous GITR ligand
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 11 Sep, 2024
"update inverses"
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors
0
Edits on 7 Aug, 2024
"update inverses"
Golden AI
edited on 7 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
0
Edits on 27 Jun, 2024
"update inverses"
Golden AI
edited on 27 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12018073 Antagonists targeting the TGF-β pathway
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12006356 Anti-CCT5 binding molecules and chimeric antigen receptors comprising the same
0
Edits on 30 May, 2024
"update inverses"
Golden AI
edited on 30 May, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11993597 Inhibitors of KRAS G12C and methods of using the same
0
Edits on 4 Apr, 2024
"update inverses"
Golden AI
edited on 4 Apr, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11945873 Antitumor antagonists
0
"update inverses"
Golden AI
edited on 4 Apr, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11944647 Articles of manufacture and methods for treatment using adoptive cell therapy
0
Edits on 12 Mar, 2024
"update inverses"
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11918584 Combination therapy including a KRAS
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11905281 KRAS G12C inhibitors and methods of using the same
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11851493 Trispecific antagonists
0
Edits on 27 Sep, 2023
"update inverses"
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11766436 KRAS G12C inhibitors and methods of using the same
Edits on 7 Jun, 2023
"update inverses"
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11667716 Bispecific antagonist comprising a LAG-3 binding domain
0
"update inverses"
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11667613 Antiviral pyrazolopyridinone compounds
0
Edits on 20 May, 2023
"Remove leading 0 from patent number"
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox
(
+1
/
-1
properties)
US Patent 08586023 Cell capable of expressing exogenous GITR ligand
US Patent 8586023 Cell capable of expressing exogenous GITR ligand
Infobox
Patent Number
08586023
Patent Number
8586023
Edits on 21 Dec, 2021
"Created via: Entity Importer"
Golden AI
created this topic on 21 Dec, 2021
Edits made to:
Infobox
(
+7
properties)
US Patent 08586023 Cell capable of expressing exogenous GITR ligand
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
08586023
Date of patent
November 19, 2013
Patent application number
13062999
Date Filed
September 11, 2009
Patent primary examiner
Marianne P Allen
Find more entities like US Patent 8586023 Cell capable of expressing exogenous GITR ligand
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE